JAZZ vs PRTA: Side-by-Side Comparison
Compare Jazz Pharmaceuticals plc (JAZZ) and Prothena Corporation plc (PRTA) side by side: market cap USD 15.28B vs USD 507.30M. Financials, growth and model signals on Bullrun.
| Metric | JAZZ | PRTA |
|---|---|---|
| Company | Jazz Pharmaceuticals plc | Prothena Corporation plc |
| Country / Exchange | Ireland · NASDAQ | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 15.28B | USD 507.30M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 4.27B | USD 9.68M |
| Revenue growth YoY | +4.9% | -92.8% |
| Net income | USD -356.15M | USD -244.09M |
| Gross margin | — | — |
| Diluted EPS | -5.84 | -4.53 |